» Articles » PMID: 15140079

CTAB-urea Method Purifies RNA from Melanin for CDNA Microarray Analysis

Overview
Specialty Cell Biology
Date 2004 May 14
PMID 15140079
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Melanin represents a major problem for the study of melanoma by microarrays since it is retained during RNA extraction and inhibits the enzymatic reactions used for probe preparation. Here we report a new method for cleaning RNA from melanin, based on the use of the cationic detergent cetyl-trimethylammonium bromide (CTAB)-urea for RNA precipitation. This method is easy to perform and has a low cost. Purified RNA is recovered with high quality and good yield. CTAB-urea treated RNA from highly pigmented melanoma cells can be successfully reverse transcribed and labeled to obtain probes which can be subsequently used in cDNA microarray experiments, giving consistent and reproducible results.

Citing Articles

Treatment resistance to melanoma therapeutics on a single cell level.

Yao L, Krasnick B, Bi Y, Sethuraman S, Goedegebuure S, Weerasinghe A Sci Rep. 2024; 14(1):21915.

PMID: 39300183 PMC: 11413001. DOI: 10.1038/s41598-024-72255-9.


LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Proteau S, Krossa I, Husser C, Gueguinou M, Sella F, Bille K EMBO Mol Med. 2023; 15(12):e17719.

PMID: 37966164 PMC: 10701601. DOI: 10.15252/emmm.202317719.


Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.

Anichini A, Molla A, Nicolini G, Perotti V, Sgambelluri F, Covre A J Exp Clin Cancer Res. 2022; 41(1):325.

PMID: 36397155 PMC: 9670381. DOI: 10.1186/s13046-022-02529-5.


Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis.

Schaettler M, Richters M, Wang A, Skidmore Z, Fisk B, Miller K Cancer Discov. 2021; 12(1):154-171.

PMID: 34610950 PMC: 9296070. DOI: 10.1158/2159-8290.CD-21-0291.


Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

Wells D, van Buuren M, Dang K, Hubbard-Lucey V, Sheehan K, Campbell K Cell. 2020; 183(3):818-834.e13.

PMID: 33038342 PMC: 7652061. DOI: 10.1016/j.cell.2020.09.015.